Evidence-Based Medicine Guidelines
Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tumour Necrosis Factor Alpha Blocking Agents (infliximab) for Induction of Remission in Ulcerative Colitis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis.
Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis. Accessed December 4, 2023.
Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis
Tumour Necrosis Factor Alpha Blocking Agents (infliximab) for Induction of Remission in Ulcerative Colitis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tumour necrosis factor alpha blocking agents (infliximab) for induction of remission in ulcerative colitis
ID - 450756
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450756/all/Tumour_necrosis_factor_alpha_blocking_agents__infliximab__for_induction_of_remission_in_ulcerative_colitis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
